Effect of Pimobendan on NT-proBNP and c troponin I before and after a submaximal exercise test in dogs with preclinical mitral valve disease without cardiomegaly – a randomised, double-blinded trial

BACKGROUND: Exercise testing in conjunction with measurement of cardiac biomarkers NT-proBNP and cTnI is a useful tool for monitoring the effect of treatment on cardiac patients. Administering Pimobendan in dogs with degenerative mitral valve disease (DMVD) and cardiomegaly results in delaying the o...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwanuk, Nayeli, Nolte, Ingo, Wall, Leona, Sehn, Maximiliane, Raue, Jonathan, Pilgram, Anna, Rumstedt, Katja, Bach, Jan-Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617668/
https://www.ncbi.nlm.nih.gov/pubmed/31288807
http://dx.doi.org/10.1186/s12917-019-1980-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617668/
https://www.ncbi.nlm.nih.gov/pubmed/31288807
http://dx.doi.org/10.1186/s12917-019-1980-z

Ejemplares similares